Does Rallies show live market data for INM?

Rallies combines live market context with ticker research for INM, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.

INM (InMed Pharmaceuticals Inc. Common Shares) Stock Analysis

InMed Pharmaceuticals Inc. Common Shares (INM) is a publicly traded Healthcare sector company. As of May 19, 2026, INM trades at $1.88 with a market cap of $2.12M and a P/E ratio of -0.08. INM moved +0.00% today. Year to date, INM is -39.22%; over the trailing twelve months it is -76.93%. Its 52-week range spans $0.58 to $8.27. Rallies surfaces INM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest INM stock research?

InMed Pharmaceuticals Inc. Common Shares (INM) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. INM moved +0.00% today.

INM Key Metrics

Key financial metrics for INM
Metric	Value
Price	$1.88
Market Cap	$2.12M
P/E Ratio	-0.08
EPS	$-8.36
Dividend Yield	0.00%
52-Week High	$8.27
52-Week Low	$0.58
Volume	10.83M
Avg Volume	0
Revenue (TTM)	$4.94M
Net Income	$-8.16M
Gross Margin	34.53%

Latest INM News

InMed Slashes Preferred Option Strike Price to $0.80 for 278,761 Shares — May 19, 2026
InMed Reports Q3 $3.0M Loss and Preclinical Data for Alzheimer’s Drug — May 6, 2026
InMed slashes exercise prices to $0.80 on 2.3M preferred options — Apr 27, 2026
InMed Notified of Sub-$1 Bid Price, Faces 180-Day Compliance Deadline — Mar 27, 2026
InMed’s INM-901 Cuts IL-6, IL-8 in 3D Brain Organoids, De-Risks Alzheimer’s Program — Mar 23, 2026

Recent INM Insider Trades

MANCINI ALEXANDRA DIANE JANET sold 240 (~$42.312) on Jul 31, 2024.
HULL ANDREW bought 37.50K (~$14.63K) on Feb 21, 2024.
ADAMS ERIC A bought 41.60K (~$14.92K) on Feb 20, 2024.

INM Analyst Consensus

INM analyst coverage data. Average price target: $0.00.

Common questions about INM

What can I research for INM on Rallies?: InMed Pharmaceuticals Inc. Common Shares (INM) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. INM moved +0.00% today.
Does Rallies show live market data for INM?: Rallies combines live market context with ticker research for INM, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.